GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?

@article{Cuatrecasas2013GHIGF1A,
  title={
GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?},
  author={G. Cuatrecasas and C. Alegre and F. Casanueva},
  journal={Pituitary},
  year={2013},
  volume={17},
  pages={277-283}
}
Fibromyalgia Syndrome (FMS) is a frequent idiopathic condition in which patients experience intense pain in specific tender points, profound fatigue and sleep disturbances. Although pain had not account so far in growth hormone deficiency syndrome (GHD) description, symptoms of FMS are very similar; and there is strong evidence of decreased GH secretion at least in a subset of FMS patients. Is there an overlap of the two diseases? A systematic Medline/Embase search for preliminary proof-of… Expand
GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome
Restless legs syndrome among women with chronic widespread pain
...
1
2
...

References

SHOWING 1-10 OF 62 REFERENCES
High prevalence of growth hormone deficiency in severe fibromyalgia syndromes.
Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.
  • P. Mease
  • Medicine
  • The Journal of rheumatology. Supplement
  • 2005
The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome.
Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome.
Are tender point injections beneficial: the role of tonic nociception in fibromyalgia.
  • R. Staud
  • Medicine
  • Current pharmaceutical design
  • 2006
Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome
...
1
2
3
4
5
...